JOHN IVERSON: Open Payments
NPI 1467864470 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 11 payments from 8 companies in 2025. Trend: 2023 $820 · 2024 $828 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Ozempic, TRELEGY ELLIPTA, QULIPTA, RECORLEV, Dexcom G6 Transmitter, Kerendia, Wegovy, OTEZLA.
Industry payments across AZ — which companies pay providers there.
